VOBYXA
LIVE

Serial Number

79221476

Owner

NOVARTIS AG

Filing Date

Aug 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

VOBYXA Trademark

Serial Number: 79221476 • Registration: 5435745

VOBYXA is a trademark filed by NOVARTIS AG on August 30, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 30, 2017

Registration Date

April 3, 2018

Published for Opposition

January 16, 2018

Cancellation Date

December 12, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Dec 25, 2025 DETH
NOTIFICATION PROCESSED BY IB
May 29, 2022 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
May 29, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 29, 2021 DETH
NOTIFICATION PROCESSED BY IB
May 25, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 7, 2018 FICS
FINAL DISPOSITION PROCESSED
May 7, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 3, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 3, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Jan 27, 2018 GPNX
PUBLISHED FOR OPPOSITION
Jan 16, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 10, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 10, 2018 OP2R
NOTICE OF PUBLICATION
Dec 27, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Dec 12, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 7, 2017 CNSA
ASSIGNED TO EXAMINER
Dec 6, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 30, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 23, 2017 REPR